Faculty Opinions recommendation of Efficacy of the β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post hoc analysis of pooled data from three randomised phase 3 trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718520609.793540478 ◽

2017 ◽

Author(s):

Lori Ann Birder

Keyword(s):

Overactive Bladder ◽

Phase 3 ◽

Post Hoc Analysis ◽

Pooled Data ◽

Adrenoceptor Agonist ◽

Download Full-text

MP33-04 EFFECTS OF THE β3-ADRENOCEPTOR AGONIST, MIRABEGRON, ON QUALITY OF LIFE IN OLDER PATIENTS WITH OVERACTIVE BLADDER: A POST-HOC ANALYSIS OF POOLED DATA FROM 3 RANDOMISED PHASE 3 TRIALS

The Journal of Urology ◽

10.1016/j.juro.2014.02.955 ◽

2014 ◽

Vol 191 (4S) ◽

Author(s):

Adrian Wagg ◽

Victor Nitti ◽

Con Kelleher ◽

Stephen Auerbach ◽

Mary Beth Blauwet ◽

...

Keyword(s):

Quality Of Life ◽

Overactive Bladder ◽

Older Patients ◽

Phase 3 ◽

Post Hoc Analysis ◽

Pooled Data ◽

Adrenoceptor Agonist ◽

Download Full-text

Efficacy of the β3-adrenoceptor Agonist Mirabegron for the Treatment of Overactive Bladder by Severity of Incontinence at Baseline: A Post Hoc Analysis of Pooled Data from Three Randomised Phase 3 Trials

European Urology ◽

10.1016/j.eururo.2014.06.052 ◽

2015 ◽

Vol 67 (1) ◽

pp. 11-14 ◽

Author(s):

Christopher Chapple ◽

Vik Khullar ◽

Victor W. Nitti ◽

Jeffrey Frankel ◽

Sender Herschorn ◽

...

Keyword(s):

Overactive Bladder ◽

Phase 3 ◽

Post Hoc Analysis ◽

Pooled Data ◽

Adrenoceptor Agonist ◽

Download Full-text

Cardiovascular safety of vibegron, a new β3‐adrenoceptor agonist, in older patients with overactive bladder: Post‐hoc analysis of a randomized, placebo‐controlled, double‐blind comparative phase 3 study

Neurourology and Urodynamics ◽

10.1002/nau.24732 ◽

2021 ◽

Author(s):

Masaki Yoshida ◽

Masayuki Takeda ◽

Momokazu Gotoh ◽

Osamu Yokoyama ◽

Hidehiro Kakizaki ◽

...

Keyword(s):

Overactive Bladder ◽

Older Patients ◽

Cardiovascular Safety ◽

Phase 3 ◽

Double Blind ◽

Post Hoc Analysis ◽

Adrenoceptor Agonist ◽

Download Full-text

Efficacy of novel β 3 ‐adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post‐hoc analysis of a randomized, double‐blind, placebo‐controlled phase 3 study

International Journal of Urology ◽

10.1111/iju.13877 ◽

2018 ◽

Vol 26 (3) ◽

pp. 369-375 ◽

Author(s):

Masaki Yoshida ◽

Masayuki Takeda ◽

Momokazu Gotoh ◽

Osamu Yokoyama ◽

Hidehiro Kakizaki ◽

...

Keyword(s):

Overactive Bladder ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Download Full-text

Efficacy of vibegron, a novel β3-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo-controlled, double-blind, comparative phase 3 study

BJU International ◽

10.1111/bju.15020 ◽

2020 ◽

Vol 125 (5) ◽

pp. 709-717 ◽

Author(s):

Masaki Yoshida ◽

Masayuki Takeda ◽

Momokazu Gotoh ◽

Osamu Yokoyama ◽

Hidehiro Kakizaki ◽

...

Keyword(s):

Urinary Incontinence ◽

Overactive Bladder ◽

Urgency Urinary Incontinence ◽

Phase 3 ◽

Double Blind ◽

Post Hoc Analysis ◽

Download Full-text

AB0902 Efficacy of tofacitinib by background methotrexate dose in patients with psoriatic arthritis: a post-hoc analysis of pooled data from 2 phase 3 trials

10.1136/annrheumdis-2018-eular.1278 ◽

2018 ◽

Author(s):

A.J. Kivitz ◽

O. FitzGerald ◽

P. Nash ◽

S. Pang ◽

V.F. Azevedo ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Phase 3 ◽

Post Hoc Analysis ◽

Pooled Data ◽

Methotrexate Dose ◽

Download Full-text

Efficacy of the novel β3 adrenergic receptor agonist vibegron for the treatment of nocturia in patients with overactive bladder: A post hoc analysis of phase 3 study

European Urology Supplements ◽

10.1016/s1569-9056(19)31437-x ◽

2019 ◽

Vol 18 (1) ◽

pp. e1984-e1985

Author(s):

M. Yoshida ◽

M. Takeda ◽

M. Goto ◽

O. Yokoyama ◽

H. Kakizaki ◽

...

Keyword(s):

Overactive Bladder ◽

Adrenergic Receptor ◽

Receptor Agonist ◽

The Novel ◽

Phase 3 ◽

Post Hoc Analysis ◽

Post Hoc ◽

Adrenergic Receptor Agonist

Download Full-text

Tu1423 Effects of Linaclotide on Straining Associated With Bowel Movements in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): A Post Hoc Analysis of Pooled Data From Two Phase 3 Trials

Gastroenterology ◽

10.1016/s0016-5085(12)63217-x ◽

2012 ◽

Vol 142 (5) ◽

pp. S-828-S-829

Author(s):

Anthony Lembo ◽

Satish S. Rao ◽

Steven J. Shiff ◽

Bernard J. Lavins ◽

James E. MacDougall ◽

...

Keyword(s):

Irritable Bowel Syndrome ◽

Phase 3 ◽

Two Phase ◽

Post Hoc Analysis ◽

Pooled Data ◽

Bowel Movements ◽

Irritable Bowel ◽

Download Full-text

Editorial Comment to Efficacy of novel β 3 ‐adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post‐hoc analysis of a randomized, double‐blind, placebo‐controlled phase 3 study

International Journal of Urology ◽

10.1111/iju.13892 ◽

2018 ◽

Vol 26 (3) ◽

pp. 375-376

Author(s):

Takeya Kitta

Keyword(s):

Overactive Bladder ◽

Editorial Comment ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Download Full-text

Editorial Comment to Efficacy of mirabegron, a β 3 ‐adrenoreceptor agonist, in Japanese women with overactive bladder and either urgency urinary incontinence or mixed urinary incontinence: Post‐hoc analysis of pooled data from two randomized, placebo‐controlled, double‐blind studies

International Journal of Urology ◽

10.1111/iju.14716 ◽

2021 ◽

Author(s):

Tomonori Yamanishi

Keyword(s):

Urinary Incontinence ◽

Overactive Bladder ◽

Editorial Comment ◽

Japanese Women ◽

Urgency Urinary Incontinence ◽

Mixed Urinary Incontinence ◽

Double Blind ◽

Post Hoc Analysis ◽

Pooled Data ◽

Download Full-text